KPV Peptide: Complete Research Overview (2026)

Interest in short-chain research peptides in Canada has grown significantly within laboratory and preclinical research communities. KPV (Lysine-Proline-Valine) is a synthetic tripeptide derived from the C-terminal region of alpha-melanocyte-stimulating hormone (α-MSH), studied in experimental settings for its peptide signalling properties and molecular interaction profile.

Written by the NexPept Research Team · Last updated: July 2026

This page provides a complete educational overview of KPV peptide for laboratory research purposes only. NexPept supplies KPV strictly for non-clinical, in vitro research applications, with an emphasis on purity, documentation, and batch consistency.

What Is KPV?

KPV is a short-chain synthetic tripeptide composed of three amino acids: Lysine (K), Proline (P), and Valine (V). It corresponds to the C-terminal tripeptide sequence of alpha-melanocyte-stimulating hormone (α-MSH), a naturally occurring tridecapeptide derived from proopiomelanocortin (POMC). KPV is synthesized for in vitro laboratory research use and is examined for its structural properties and role in peptide signalling pathway research.

Due to its short-chain structure and derivation from a well-characterized endogenous peptide, KPV is frequently examined in research environments focused on peptide stability, structure–function relationships, and melanocortin receptor interaction studies in vitro.

KPV Molecular Profile

Why Researchers Study KPV

In laboratory and preclinical research environments, KPV peptide has been investigated for its potential involvement in peptide signalling pathway research and molecular interaction studies. As a C-terminal fragment of α-MSH, it shares structural features with the parent peptide that have made it relevant to research examining melanocortin-related signalling in in vitro models.

Because of its tripeptide length, KPV occupies an interesting structural position in peptide research — short enough to study as an isolated signalling fragment, yet complex enough to exhibit receptor interaction properties associated with the full α-MSH sequence. This makes it a useful research tool in studies examining short-chain peptide pharmacology in controlled experimental systems.

Research applications include:

• Peptide signalling pathway research in vitro
• Melanocortin receptor interaction studies
• Molecular interaction and structure–function analysis
• Short-chain peptide stability and behaviour research
• Experimental cellular research models examining α-MSH fragments
• Comparative studies of truncated vs. full-length melanocortin peptides

KPV and the α-MSH Connection

Understanding KPV's origin within the α-MSH sequence is important for interpreting its research profile. Alpha-melanocyte-stimulating hormone (α-MSH) is a 13-amino-acid neuropeptide processed from proopiomelanocortin (POMC). The full sequence of α-MSH terminates in the tripeptide Lys-Pro-Val — the sequence that defines KPV.

Research interest in this C-terminal fragment arose from studies examining which portions of α-MSH retain structural activity at melanocortin receptors. As a result, KPV is studied as an isolated structural probe in melanocortin receptor binding research and has been examined in various in vitro models as a minimal active fragment of the parent peptide.

This derivation from a well-characterized endogenous signalling molecule makes KPV particularly relevant to researchers building structure–activity relationship (SAR) datasets for the melanocortin peptide family.

Purity & Documentation for KPV Research

High peptide purity is critical for reproducible in vitro research outcomes, particularly for short-chain peptides like KPV, where impurities represent a proportionally larger fraction of the sample by molecular weight. Variations in synthesis quality or incomplete documentation can significantly affect experimental data in signalling studies.

When evaluating a KPV peptide supplier in Canada, researchers should look for:

• Third-party analytical testing — HPLC and mass spectrometry performed by an independent laboratory
• Batch-specific identification — each vial traceable to a documented production lot with its own COA
• Verified purity percentages — ≥99% purity is the accepted benchmark for research-grade peptides
• Certificates of Analysis (COAs) from independent laboratories, not in-house supplier testing
• MS confirmation — mass spectrometry verifying molecular identity alongside HPLC purity data

NexPept provides third-party COAs for every KPV batch. Researchers can view COAs here or contact us to verify any batch directly with the testing laboratory.

Storage & Handling (Research Use Only)

Proper storage and handling are essential to preserving the integrity of KPV peptide in laboratory settings. As a short-chain lyophilized peptide, KPV is sensitive to moisture and light exposure — factors that can degrade both the peptide backbone and any secondary structure relevant to its research properties.

General laboratory storage considerations for KPV include:

• Store sealed lyophilized material under controlled laboratory conditions in accordance with your institution's validated SOPs
• Protect from moisture and prolonged light exposure at all times
• Keep vials sealed until required for experimental use
• Adhere to institution-approved handling and storage protocols for lyophilized short-chain peptides
• Always follow your laboratory's established procedures

Sourcing KPV Research Peptides in Canada

When sourcing KPV peptide in Canada, researchers typically prioritize consistent quality, transparent documentation, and reliable domestic shipping. Canadian-based suppliers eliminate customs delays and temperature-chain uncertainties associated with international sourcing — important considerations for sensitive lyophilized short-chain peptides.

Key factors to evaluate when choosing a KPV supplier in Canada:

• Independent third-party testing with verifiable COAs
• Clear research-use-only labeling on all products
• Batch-specific documentation and lot traceability
• Transparent molecular data — CAS, formula, purity method clearly stated
• Reliable Canadian shipping with tracking through Canada Post or FedEx

How to Compare KPV Peptide Suppliers in Canada

With growing interest in KPV research peptides in Canada, the number of suppliers has expanded. Not all operate to the same documentation and testing standards. The most important differentiator is independent third-party testing — a COA issued by an external laboratory that can be verified by the researcher, rather than internally produced documentation.

Second, evaluate batch traceability. Each production lot of KPV should be individually documented, so the vial you receive can be linked to a specific COA. Third, consider domestic shipping reliability — Canadian-based suppliers shipping via tracked domestic carriers provide 1–5 business day delivery with no customs risk. Finally, assess labeling transparency: a trustworthy supplier will clearly label KPV as a research-use-only compound with no dosing, reconstitution, or administration claims.

Related Research Peptides Available in Canada

Researchers exploring KPV peptide may also be interested in related short-chain peptides and other Canadian research compounds with overlapping research contexts:

• Ipamorelin Research Peptide Overview — a pentapeptide growth hormone secretagogue studied in endocrine and metabolic research
• GHK-Cu Research Peptide Overview — a naturally occurring copper-binding tripeptide with an established preclinical literature base
• Buy Peptides Canada — full catalogue of lab-tested research peptides available in Canada
• Research Peptides in Canada — sourcing, regulation, and quality guidance for Canadian researchers
• What Are Research Peptides? — classification and in vitro research context

Common Questions About KPV Peptide

KPV Peptide Research: Key Points

• KPV (Lys-Pro-Val) is a synthetic tripeptide, CAS 69279-49-8, MW ~340.4 Da
• Derived from the C-terminal tripeptide sequence of alpha-melanocyte-stimulating hormone (α-MSH)
• Studied in vitro for melanocortin receptor interaction, peptide signalling, and structure–function analysis
• Supplied as lyophilized powder — 10 mg per vial
• Verified to ≥99% purity by independent HPLC and mass spectrometry
• Batch-specific COAs available from NexPept
• Not authorized by Health Canada for human or veterinary use
• Available domestically in Canada with tracked shipping nationwide

This guide is intended to provide a complete research overview of KPV peptide for Canadian laboratory researchers. Understanding molecular profile, sourcing standards, and documentation requirements helps support more consistent and reliable in vitro research outcomes when working with short-chain research peptides in Canada.